David L. Severson

5.2k total citations
86 papers, 4.3k citations indexed

About

David L. Severson is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, David L. Severson has authored 86 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 39 papers in Cardiology and Cardiovascular Medicine and 26 papers in Physiology. Recurrent topics in David L. Severson's work include Cardiovascular Function and Risk Factors (29 papers), Adipose Tissue and Metabolism (21 papers) and Metabolism, Diabetes, and Cancer (18 papers). David L. Severson is often cited by papers focused on Cardiovascular Function and Risk Factors (29 papers), Adipose Tissue and Metabolism (21 papers) and Metabolism, Diabetes, and Cancer (18 papers). David L. Severson collaborates with scholars based in Canada, Norway and United States. David L. Severson's co-authors include Terje S. Larsen, Darrell D. Belke, Ellen Aasum, Andrew N. Carley, E. Michael Gibbs, George I. Drummond, Anne D. Hafstad, Lisa Semeniuk, Albert Kryski and Philip J. Randle and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Physiology.

In The Last Decade

David L. Severson

85 papers receiving 4.2k citations

Peers

David L. Severson
Sylvia A. McCune United States
John J. Lehman United States
David Grieve United Kingdom
Ming-Hui Zou United States
Ming‐Hui Zou United States
Balvin H.L. Chua United States
Teresa C. Leone United States
David L. Severson
Citations per year, relative to David L. Severson David L. Severson (= 1×) peers Jagdip S. Jaswal

Countries citing papers authored by David L. Severson

Since Specialization
Citations

This map shows the geographic impact of David L. Severson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Severson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Severson more than expected).

Fields of papers citing papers by David L. Severson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Severson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Severson. The network helps show where David L. Severson may publish in the future.

Co-authorship network of co-authors of David L. Severson

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Severson. A scholar is included among the top collaborators of David L. Severson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Severson. David L. Severson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scheman, Andrew, Kevin R. Patel, David L. Severson, et al.. (2020). Relative Prevalence of Contact Allergens in North America in 2018. Dermatitis. 31(2). 112–121. 9 indexed citations
2.
Scheman, Andrew, et al.. (2017). Contact Allergy Cross-reactions: Retrospective Clinical Data and Review of the Literature. Dermatitis. 28(2). 128–140. 11 indexed citations
3.
Scheman, Andrew & David L. Severson. (2016). American Contact Dermatitis Society Contact Allergy Management Program: An Epidemiologic Tool to Quantify Ingredient Usage. Dermatitis. 27(1). 11–13. 20 indexed citations
5.
Hafstad, Anne D., Ahmed M. Khalid, Trine Meldgaard Lund, et al.. (2009). Cardiac peroxisome proliferator-activated receptor-α activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss. Cardiovascular Research. 83(3). 519–526. 54 indexed citations
6.
Boardman, Neoma T., Anne D. Hafstad, Terje S. Larsen, David L. Severson, & Ellen Aasum. (2009). Increased O2 cost of basal metabolism and excitation-contraction coupling in hearts from type 2 diabetic mice. American Journal of Physiology-Heart and Circulatory Physiology. 296(5). H1373–H1379. 42 indexed citations
7.
Shearer, Jane, David L. Severson, Lin Su, Luiz Belardinelli, & Arvinder K. Dhalla. (2008). Partial A1 Adenosine Receptor Agonist Regulates Cardiac Substrate Utilization in Insulin-Resistant Rats in Vivo. Journal of Pharmacology and Experimental Therapeutics. 328(1). 306–311. 17 indexed citations
8.
Aasum, Ellen, Marie Cooper, David L. Severson, & Terje S. Larsen. (2005). Effect of BM 17.0744, a PPARα ligand, on the metabolism of perfused hearts from control and diabetic mice. Canadian Journal of Physiology and Pharmacology. 83(2). 183–190. 32 indexed citations
9.
Ding, Hong, Andrew G. Howarth, Malarvannan Pannirselvam, et al.. (2005). Endothelial dysfunction in Type 2 diabetes correlates with deregulated expression of the tail-anchored membrane protein SLMAP. American Journal of Physiology-Heart and Circulatory Physiology. 289(1). H206–H211. 21 indexed citations
10.
Carroll, Rogayah, Andrew N. Carley, Jason R.B. Dyck, & David L. Severson. (2005). Metabolic effects of insulin on cardiomyocytes from control and diabeticdb/dbmouse hearts. American Journal of Physiology-Endocrinology and Metabolism. 288(5). E900–E906. 44 indexed citations
11.
Carley, Andrew N. & David L. Severson. (2005). Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1734(2). 112–126. 174 indexed citations
12.
Severson, David L.. (2004). Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. Canadian Journal of Physiology and Pharmacology. 82(10). 813–823. 94 indexed citations
13.
Belke, Darrell D., Sandrine Bétuing, Christophe Graveleau, et al.. (2002). Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. Journal of Clinical Investigation. 109(5). 629–639. 278 indexed citations
14.
Larsen, Terje S., Darrell D. Belke, Wayne R. Giles, et al.. (1999). The isolated working mouse heart: methodological considerations. Pflügers Archiv - European Journal of Physiology. 437(6). 979–985. 54 indexed citations
15.
Liu, Limin & David L. Severson. (1995). Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia. Canadian Journal of Physiology and Pharmacology. 73(3). 369–377. 4 indexed citations
16.
Liu, Limin & David L. Severson. (1994). Regulation of myocardial lipoprotein lipase activity by diabetes and thyroid hormones. Canadian Journal of Physiology and Pharmacology. 72(11). 1259–1264. 5 indexed citations
17.
Rodrigues, Brian, et al.. (1992). Long term incubation of cardiac myocytes with oleic acid and very-low density lipoprotein reduces heparin-releasable lipoprotein lipase activity. Molecular and Cellular Biochemistry. 116(1-2). 33–37. 4 indexed citations
18.
Yang, Song‐Gui, et al.. (1991). Diacylglycerol lipase and the contractile action of epidermal growth factor-urogastrone: evidence for distinct signal pathways in a single strip of gastric smooth muscle. European Journal of Pharmacology Molecular Pharmacology. 207(3). 225–230. 17 indexed citations
19.
Larsen, Terje S. & David L. Severson. (1990). Influence of exogenous fatty acids and ketone bodies on rates of lipolysis in isolated ventricular myocytes from normal and diabetic rats. Canadian Journal of Physiology and Pharmacology. 68(9). 1177–1182. 8 indexed citations
20.
Severson, David L., Mark Lee, & Rogayah Carroll. (1988). Secretion of lipoprotein lipase from myocardial cells isolated from adult rat hearts. Molecular and Cellular Biochemistry. 79(1). 17–24. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026